IOVA Stock Could See Another Massive Rebound

Analysts have been resoundingly optimistic over the pharma stock

Digital Content Manager
Aug 14, 2019 at 1:04 PM
facebook X logo linkedin

Iovance Biotherapeutics Inc (NASDAQ:IOVA) has had quite the year. The stock saw a massive post-earnings bull gap in May and subsequently rode its 10-day moving average straight towards a five year peak of $26.59 late last month. What's more, IOVA just landed on Senior Quantitative Analyst Rocky White's list of stocks nearing a 50% year-over-year gain just last week. And while the stock has cooled since reaching this peak, it just showed up in another study from White with historically bullish implications for the pharma concern. 

White's study shows that the equity just pulled back to its 70-day moving average after a lengthy period atop the trendline. According to White's data, this signal has flashed seven times before, and ended positive one month later 86% of the time. What's more, the stock has averaged a whopping one-month return of 26.1%, which would place IOVA right below its five-year peak, based on the stock's current perch of $20.70. 

IOVA Chart Aug 14

Analysts feel confident in the drugmaker too, with all nine calling the stock a "strong buy." Plus, the consensus 12-month price target of $33.63 hasn't been touched since 2013, and holds a roughly 62% premium to current levels. 

It looks like short-term options traders are in agreement, according to IOVA's Schaeffer's put/call open interest ratio (SOIR) of 0.06, which sits lower than all but 3% of readings from the past year, suggesting an unusually heavy appetite for calls among short-term options players. Likewise, the equity sports an eyebrow-raising 10-day call/put volume ratio of 92.33 on the International Securities Exchange (ISE), Cboe Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX). 

Despite this generally bullish sentiment, short interest has inched 2.7% higher in the last two reporting periods to 13.66 million shares sold short. These pessimistic positions have a grasp on 19.1% of the stock's available float, and represent nearly seven days' worth of trading at IOVA's average pace. Should the security shoot back up the charts, an unwinding of bearish bets could put even more wind at IOVA's back. 


Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on calls
238.5% GAIN on Oracle calls



Rainmaker Ads CGI